234 related articles for article (PubMed ID: 29870976)
41. Influence of the pH Value of Refluxate and Proximal Extent on Heartburn Perception in Patients with Proton Pump Inhibitor-Refractory Non-Erosive Reflux Disease.
Abe Y; Koike T; Saito M; Okata T; Norita K; Kikuchi H; Nakagawa K; Hatta W; Asanuma K; Uno K; Asano N; Imatani A; Shimosegawa T; Masamune A
Digestion; 2020; 101(4):375-381. PubMed ID: 31357199
[TBL] [Abstract][Full Text] [Related]
42. [Esophageal pH-impedance monitoring of reflux patterns in non-erosive reflux disease, reflux hypersensitivity and functional heartburn].
Zhang A; Yao W; Di J; Cui M; Zhang M; Zhang J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Oct; 40(10):1507-1512. PubMed ID: 33118504
[TBL] [Abstract][Full Text] [Related]
43. Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.
Malfertheiner P; Lind T; Willich S; Vieth M; Jaspersen D; Labenz J; Meyer-Sabellek W; Junghard O; Stolte M
Gut; 2005 Jun; 54(6):746-51. PubMed ID: 15888776
[TBL] [Abstract][Full Text] [Related]
44. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.
Hershcovici T; Jha LK; Fass R
J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040
[TBL] [Abstract][Full Text] [Related]
45. Untangling Nonerosive Reflux Disease From Functional Heartburn.
Patel D; Fass R; Vaezi M
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1314-1326. PubMed ID: 32246998
[TBL] [Abstract][Full Text] [Related]
46. The value of early wireless esophageal pH monitoring in diagnosing functional heartburn in refractory gastroesophageal reflux disease.
Park EY; Choi MG; Baeg M; Lim CH; Kim J; Cho Y; Park J; Lee I; Kim S; Choi K
Dig Dis Sci; 2013 Oct; 58(10):2933-9. PubMed ID: 23765257
[TBL] [Abstract][Full Text] [Related]
47. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
48. Predicting the efficacy of proton pump inhibitors in patients with non-erosive reflux disease before therapy using dual-channel 24-h esophageal pH monitoring.
Shimatani T; Sugimoto M; Nishino M; Adachi K; Furuta K; Ito M; Kurosawa S; Manabe N; Mannen K; Hongo M; Chiba T; Kinoshita Y;
J Gastroenterol Hepatol; 2012 May; 27(5):899-906. PubMed ID: 22098590
[TBL] [Abstract][Full Text] [Related]
49. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
[TBL] [Abstract][Full Text] [Related]
50. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y
Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
[TBL] [Abstract][Full Text] [Related]
51. [Esophageal motility characteristics of refractory heartburn: a study based on high resolution manometry and 24 hour pH-impedance monitoring].
Wang K; Duan L; Xia Z; Xu Z; Ge Y
Zhonghua Yi Xue Za Zhi; 2014 Sep; 94(34):2650-5. PubMed ID: 25511590
[TBL] [Abstract][Full Text] [Related]
52. Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.
Yamashita H; Ashida K; Fukuchi T; Nagatani Y; Koga H; Senda K; Eguchi T; Ubukata S; Kawaguchi S; Ueda A; Tanaka T; Ohashi R; Ito D
J Smooth Muscle Res; 2012; 48(5-6):125-35. PubMed ID: 23538509
[TBL] [Abstract][Full Text] [Related]
53. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
Masiak W; Wallner G; Wallner J; Pedowski T; Solecki M
Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
[TBL] [Abstract][Full Text] [Related]
54. Clinical Characterization of Vonoprazan-Refractory Gastroesophageal Reflux Disease.
Hamada S; Ihara E; Ikeda H; Muta K; Ogino H; Chinen T; Tanaka Y; Ogawa Y
Digestion; 2021; 102(2):197-204. PubMed ID: 31578027
[TBL] [Abstract][Full Text] [Related]
55. Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy.
Mandaliya R; DiMarino AJ; Cohen S
Dis Esophagus; 2016 Jan; 29(1):27-33. PubMed ID: 25294046
[TBL] [Abstract][Full Text] [Related]
56. Correlation between hypersensitivity induced by esophageal acid infusion and the baseline impedance level in patients with suspected gastroesophageal reflux.
Seo AY; Shin CM; Kim N; Yoon H; Park YS; Lee DH
J Gastroenterol; 2015 Jul; 50(7):735-43. PubMed ID: 25479939
[TBL] [Abstract][Full Text] [Related]
57. [Functional heartburn--update 2013].
Storr M
MMW Fortschr Med; 2013 Dec; 155 Suppl 4():100-3. PubMed ID: 24934062
[TBL] [Abstract][Full Text] [Related]
58. Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment.
Miwa H; Kondo T; Oshima T
Curr Opin Gastroenterol; 2016 Jul; 32(4):344-52. PubMed ID: 27206157
[TBL] [Abstract][Full Text] [Related]
59. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
60. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn.
Frazzoni M; de Bortoli N; Frazzoni L; Furnari M; Martinucci I; Tolone S; Farioli A; Marchi S; Fuccio L; Savarino V; Savarino E
J Gastroenterol; 2017 Apr; 52(4):444-451. PubMed ID: 27241210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
